Table 3.

Correlation between liver status and epidemiologic and clinical features of the 88 HCV-RNA–positive hemophilic patients

FeaturesNormal ALT levels
(n = 15)
Chronic hepatitis
(n = 61)
Severe liver disease3-150
(n = 12)
P3-151
Median age, y (range) 43.1  (15-67) 44.6  (25-70) 52.1  (26-68) .02   
Median age at infection, y (range) 22.3  (1-56) 19.6  (1-52) 22.0  (1-42) NS   
Median duration of infection, y (range) 21.1  (15-32) 25.0  (15-50) 29.6  (15-36) .03  
Sex     
 Male 13  (86.7)3-152 52  (85.2)3-152 10  (83.3)3-152 NS   
 Female 2  (13.3)3-152 9  (14.7)3-152 2  (16.7)3-152  
Diagnosis     
 Mild/moderate hemophilia 8  (53.3)3-152 30  (49.2)3-152 3  (25.0)3-152 < .01   
 Severe hemophilia 3  (20.0)3-152 21  (34.4)3-152 7  (58.3)3-152 < .001  
 von Willebrand disease 4  (26.7)3-152 10  (16.4)3-152 2  (16.7)3-152 NS  
FeaturesNormal ALT levels
(n = 15)
Chronic hepatitis
(n = 61)
Severe liver disease3-150
(n = 12)
P3-151
Median age, y (range) 43.1  (15-67) 44.6  (25-70) 52.1  (26-68) .02   
Median age at infection, y (range) 22.3  (1-56) 19.6  (1-52) 22.0  (1-42) NS   
Median duration of infection, y (range) 21.1  (15-32) 25.0  (15-50) 29.6  (15-36) .03  
Sex     
 Male 13  (86.7)3-152 52  (85.2)3-152 10  (83.3)3-152 NS   
 Female 2  (13.3)3-152 9  (14.7)3-152 2  (16.7)3-152  
Diagnosis     
 Mild/moderate hemophilia 8  (53.3)3-152 30  (49.2)3-152 3  (25.0)3-152 < .01   
 Severe hemophilia 3  (20.0)3-152 21  (34.4)3-152 7  (58.3)3-152 < .001  
 von Willebrand disease 4  (26.7)3-152 10  (16.4)3-152 2  (16.7)3-152 NS  

HCV indicates hepatitis C virus; ALT, alanine aminotransferase; NS, not significant.

F3-150

Severe liver disease = liver cirrhosis, hepatic decompensation, and hepatocellular carcinoma.

F3-151

P value = severe liver disease versus normal ALT levels and chronic hepatitis.

F3-152

Number (percentage).

Close Modal

or Create an Account

Close Modal
Close Modal